跳至主要内容
临床试验/ACTRN12622001344785
ACTRN12622001344785招募中未知

Investigating the effect of caffeine to improve neurodevelopmental outcomes in babies born late preterm: a randomised controlled trial

niversity of Auckland0 个研究点目标入组 478 人开始时间: 2022年10月19日最近更新:
适应症

试验速览

阶段
未知
状态
招募中
发起方
入组人数
478

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional
分配方式
Randomised controlled trial
主要目的
Prevention
盲法
Blinded (masking used)

入排标准

年龄范围
o limit 至 72 Hours(—)
性别
All

入选标准

  • Babies born between 34+0 and 36+6 weeks’ gestational age without contra-indication to caffeine treatment.

排除标准

  • Major congenital abnormality
  • Minor congenital abnormality likely to affect respiration, growth, or development
  • Previous caffeine treatment
  • Renal or hepatic impairment
  • Tachyarrhythmia
  • Hypoxic ischaemic encephalopathy
  • Maternal age less than 16 years
  • More than 72 hours after birth
  • Multiple births of triplets or higher

研究者

发起方
niversity of Auckland

相似试验

Investigating the effect of caffeine to improve... | 临床试验